ART. 101(1) TFEU: A Bitter Pill for Hoffmann-La Roche 26 February 2018/ By Martin Herz and Justin Lindeboom
AG Saugmandsgaard Øe in C-329/15: Towards a novel approach to the state resources criterion? 18 April 2017/ By Gian Marco Galletti
Lundbeck: Remedying IP Overprotection through Competition Law Enforcement in the Pharma Sector 22 November 2016/ By Konstantinos Sidiropoulos
The Spanish Tax Lease case: identifying the beneficiary under the selectivity test in fiscal aid schemes 15 June 2016/ By Sébastien Thomas
Pernicious Effect of Similar Medicinal Product’s Orphan Exclusivity: CJEU Dismisses Teva’s Appeal (C-138/15 P) 11 April 2016/ By Mayank Dixit